Aug 3, 2026 11:24AM
Aug 3, 2026 08:17AM
Aug 3, 2026 05:51AM
May 12, 2026 04:01PM
May 12, 2026 04:01PM
Mar 18, 2026 09:21AM
Nov 3, 2025 04:55AM Bristol Myers Squibb Announces Cash Tender Offers to Purchase Certain Notes
Oct 14, 2025 04:00PM
Oct 14, 2025 04:00PM
Oct 10, 2025 06:59AM
Oct 10, 2025 06:59AM
Jul 17, 2025 10:38AM
Jun 2, 2025 07:38AM
Apr 24, 2025 06:59AM Bristol Myers Squibb Reports First Quarter Financial Results for 2025
Mar 20, 2025 08:00AM
Mar 15, 2025 04:00PM
Mar 10, 2025 10:17PM
Mar 10, 2025 10:17PM
Feb 6, 2025 06:59AM
Jan 22, 2025 08:30AM
Nov 19, 2024 06:59AM Bristol Myers Squibb’s Presentations at ASH 2024 Reinforce Strength of Hematology Portfolio and Scientific Advances in Differentiated Research Platforms
Oct 31, 2024 06:59AM
Sep 27, 2024 08:20AM
Sep 27, 2024 08:05AM
Sep 27, 2024 07:06AM
Sep 27, 2024 06:54AM
Sep 27, 2024 06:07AM
Sep 27, 2024 02:00AM PureTech-Invented KarXT Receives U.S. Food and Drug Administration Approval for the Treatment of Schizophrenia in Adults
Aug 28, 2024 02:01AM
Jul 26, 2024 06:59AM
May 23, 2024 05:05PM
Apr 25, 2024 07:26AM
Apr 25, 2024 06:59AM
Apr 25, 2024 05:22AM
Apr 3, 2024 04:02PM Standard BioTools (LAB) Announces Multi-Year Strategic Engagement with Bristol Myers Squibb (BMY) for SomaScan Platform in Translational Medicine Research
Apr 2, 2024 08:21PM
Apr 2, 2024 08:08PM
Mar 28, 2024 07:30AM
Mar 18, 2024 09:52AM
Mar 18, 2024 08:45AM
Mar 18, 2024 08:44AM
Mar 14, 2024 07:50AM Karuna Therapeutics (KRTX) Discloses Termination of HSR Waiting Period for Bristol-Myers (BMY) Deal
Feb 29, 2024 06:45AM
Feb 26, 2024 08:36AM
Feb 26, 2024 08:35AM
Feb 23, 2024 06:59AM
Feb 23, 2024 06:59AM
Feb 23, 2024 06:59AM
Feb 23, 2024 06:59AM Bristol Myers Squibb Receives Positive CHMP Opinion for Reblozyl® (luspatercept) for Treatment of Adults with Transfusion-Dependent Anemia due to Low- to Intermediate-Risk Myelodysplastic Syndromes (
Feb 20, 2024 01:11PM

1,174,431 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All